No Data
No Data
Express News | Cardlytics Inc : BofA Global Research Reinstates Coverage With Neutral Rating; Price Objective $11
Cardlytics Price Target Announced at $11.00/Share by B of A Securities
Cardlytics Price Target Announced at $11.00/Share by B of A Securities
B of A Securities Reinstates Neutral on Cardlytics, Announces $11 Price Target
B of A Securities analyst Omar Dessouky reinstates Cardlytics (NASDAQ:CDLX) with a Neutral and announces $11 price target.
BofA Securities Initiates Cardlytics(CDLX.US) With Hold Rating, Announces Target Price $11
BofA Securities analyst Omar Dessouky initiates coverage on $Cardlytics(CDLX.US)$ with a hold rating, and sets the target price at $11.According to TipRanks data, the analyst has a success rate of 45.
Express News | Cardlytics Inc : Northland Capital Initiates Coverage With Outperform Rating; Target Price $14
Cardlytics Initiated at Outperform by Northland Capital Markets
Cardlytics Initiated at Outperform by Northland Capital Markets